Faculty Opinions recommendation of Automated EEG source imaging: A retrospective, blinded clinical validation study.

Author(s):  
Christoph Baumgartner
2018 ◽  
Vol 129 (11) ◽  
pp. 2403-2410 ◽  
Author(s):  
Amir G. Baroumand ◽  
Pieter van Mierlo ◽  
Gregor Strobbe ◽  
Lars H. Pinborg ◽  
Martin Fabricius ◽  
...  

Author(s):  
Amir G. Baroumand ◽  
Anca A. Arbune ◽  
Gregor Strobbe ◽  
Vincent Keereman ◽  
Lars H. Pinborg ◽  
...  

2020 ◽  
Vol 65 (6) ◽  
pp. 673-682
Author(s):  
Pegah Khosropanah ◽  
Eric Tatt-Wei Ho ◽  
Kheng-Seang Lim ◽  
Si-Lei Fong ◽  
Minh-An Thuy Le ◽  
...  

AbstractEpilepsy surgery is an important treatment modality for medically refractory focal epilepsy. The outcome of surgery usually depends on the localization accuracy of the epileptogenic zone (EZ) during pre-surgical evaluation. Good localization can be achieved with various electrophysiological and neuroimaging approaches. However, each approach has its own merits and limitations. Electroencephalography (EEG) Source Imaging (ESI) is an emerging model-based computational technique to localize cortical sources of electrical activity within the brain volume, three-dimensionally. ESI based pre-surgical evaluation gives an overall clinical yield of 73–91%, depending on choice of head model, inverse solution and EEG electrode density. It is a cost effective, non-invasive method which provides valuable additional information in presurgical evaluation due to its high localizing value specifically in MRI-negative cases, extra or basal temporal lobe epilepsy, multifocal lesions such as tuberous sclerosis or cases with multiple hypotheses. Unfortunately, less than 1% of surgical centers in developing countries use this method as a part of pre-surgical evaluation. This review promotes ESI as a useful clinical tool especially for patients with lesion-negative MRI to determine EZ cost-effectively with high accuracy under the optimized conditions.


Author(s):  
Lukas Hecker ◽  
Rebekka Rupprecht ◽  
Ludger Tebartz van Elst ◽  
Juergen Kornmeier

AbstractEEG and MEG are well-established non-invasive methods in neuroscientific research and clinical diagnostics. Both methods provide a high temporal but low spatial resolution of brain activity. In order to gain insight about the spatial dynamics of the M/EEG one has to solve the inverse problem, which means that more than one configuration of neural sources can evoke one and the same distribution of EEG activity on the scalp. Artificial neural networks have been previously used successfully to find either one or two dipoles sources. These approaches, however, have never solved the inverse problem in a distributed dipole model with more than two dipole sources. We present ConvDip, a novel convolutional neural network (CNN) architecture that solves the EEG inverse problem in a distributed dipole model based on simulated EEG data. We show that (1) ConvDip learned to produce inverse solutions from a single time point of EEG data and (2) outperforms state-of-the-art methods (eLORETA and LCMV beamforming) on all focused performance measures. (3) It is more flexible when dealing with varying number of sources, produces less ghost sources and misses less real sources than the comparison methods. (4) It produces plausible inverse solutions for real-world EEG recordings and needs less than 40 ms for a single forward pass. Our results qualify ConvDip as an efficient and easy-to-apply novel method for source localization in EEG and MEG data, with high relevance for clinical applications, e.g. in epileptology and real time applications.


SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A161-A161
Author(s):  
Chris Fernandez ◽  
Sam Rusk ◽  
Nick Glattard ◽  
Yoav Nygate ◽  
Fred Turkington ◽  
...  

Abstract Introduction Despite an appreciable rise in sleep wellness and sleep medicine A.I. research publications, public data corpuses, institutional support, and health A.I. research funding opportunities, the availability of controlled-retrospective, hybrid-retrospective-prospective, and prospective-RCT quality clinical validation study evidence is limited with respect to their potential clinical impact. Furthermore, only a few practical examples of A.I. technologies are validated, in use today clinically, and widely adopted, to assist in sleep diagnoses and treatment. In this study, we contribute to this growing body of clinical A.I. validation evidence and experimental design methodologies with an interoperable A.I. scoring engine in Adult and Pediatric populations. Methods Stratified random sampling with proportionate allocation was applied to a database of N>10,000 retrospective diagnostic clinical polysomnography (PSG), selected by evidence grading standards, with controls applied for OSA severity, diagnoses; sleep, psychiatric, neurologic, neurodevelopmental, cardiac, pulmonary, metabolic disorders, medications; benzodiazepines, antidepressants, stimulants, opiates, sleep aids, demographic groups of interest; sex, adult age, pediatric age, BMI, weight, height, and patient-reported sleepiness, to establish representative N=100 Adult and N=100 Pediatric samples. Double Blinded scoring was prospectively collected for each sample by 3 experienced RPSGT certified sleep technologists randomized from a pool of 9 scorers. Sensitivity (PA), Specificity (NA), Accuracy (OA), Kappa (K), and 95% Bootstrap CI’s are presented for sleep stages, OSA/CSA, hypopnea 3%/4%, arousals, limb movements, Cheyenne-Stokes respiration, periodic breathing, atrial fibrillation, and other events, and normative, mild, moderate, and severe OSA categories for global-AHI and REM-AHI. Results for Sleep Staging and OSA Severity Diagnostic Accuracy are summarized. Results A.I. scoring performance meet but in most cases exceeded initial clinical validation study (N=72 Adults, 2017) PA, NA, OA, K point-estimates and confidence-interval results for the 26 event types and 8 AHI-categories evaluated. The Adult sample showed 87%/94% Sensitivity/Specificity across all stages (Wake/N1/N2/N3/REM) and 94%/96% Sensitivity/Specificity for AHI>=15. The Pediatric sample showed 87%/93% Sensitivity/Specificity staging, 89%/98% Sensitivity/Specificity AHI>=15. Observed Accuracy was >90% for Adults and Pediatrics all 26 events and 7 AHI-categories analyzed, except REM-AHI>=5 (85%/82% Adults/Pediatrics). Conclusion We provide clinical validation evidence that demonstrates interoperable A.I. scoring performance in representative Adult and Pediatric patient clinical PSG samples when compared to prospective, double-blind scoring panel. Support (if any):


2020 ◽  
Vol 2020 ◽  
pp. 1-15
Author(s):  
Yohan Céspedes-Villar ◽  
Juan David Martinez-Vargas ◽  
G. Castellanos-Dominguez

Electromagnetic source imaging (ESI) techniques have become one of the most common alternatives for understanding cognitive processes in the human brain and for guiding possible therapies for neurological diseases. However, ESI accuracy strongly depends on the forward model capabilities to accurately describe the subject’s head anatomy from the available structural data. Attempting to improve the ESI performance, we enhance the brain structure model within the individual-defined forward problem formulation, combining the head geometry complexity of the modeled tissue compartments and the prior knowledge of the brain tissue morphology. We validate the proposed methodology using 25 subjects, from which a set of magnetic-resonance imaging scans is acquired, extracting the anatomical priors and an electroencephalography signal set needed for validating the ESI scenarios. Obtained results confirm that incorporating patient-specific head models enhances the performed accuracy and improves the localization of focal and deep sources.


2019 ◽  
Vol 30 (7) ◽  
pp. 1062-1068.e2 ◽  
Author(s):  
Nischal Koirala ◽  
Nikunj Chauhan ◽  
Dustin Thompson ◽  
Zahra Karimloo ◽  
Kevin Wunderle ◽  
...  

2017 ◽  
Vol 31 (3) ◽  
pp. 392-406 ◽  
Author(s):  
G. McLoughlin ◽  
J. Palmer ◽  
S. Makeig ◽  
N. Bigdely-Shamlo ◽  
T. Banaschewski ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document